Merck, the New Jersey-based drug giant, is spending $1 billion on a new Delaware factory to bring production of its best-selling cancer drug Keytruda to the U.S. and speed future drugs to market.

The firm said that its overall revenues rose 2 percent year over year and 4 percent on an organic basis with a smaller increase in its life sciences revenues.

Enhancing wheat plants' sugar signaling ability could deliver increased yields of up to 12%, according to researchers from ...

Commissioners visit UD-based NIIMBL, where public-private partnerships promote innovation, workforce development ...

India is reportedly seeking duty concessions for labour-intensive sectors like textiles, gems and jewellery, leather goods, ...

The US wants duty concessions in sectors like certain industrial goods, automobiles (electric vehicles particularly), wines, ...

The US remained India's largest trading partner for the fourth consecutive year in 2024-25 with bilateral trade valued at USD ...

Piyush Goyal stated that India frequently receives requests to extend pharmaceutical patents for minor modifications. He ...

The quiet rise of K18—a premium haircare brand with a scientific soul—offers a textbook case of what modern consumers want, and what luxury brands must now deliver. Not louder claims. Not flashier ...

India aims to secure access to critical US technologies, including AI, telecom, and semiconductors, in proposed trade pact ...

Positive IND-enabling data on MP0712 targeting DLL3, the most advanced Radio-DARPin program in co-development with Orano Med, entering clinical development in 2025 First preclinical data of novel targ ...

RNA-based technologies are a powerful molecular biology toolbox, empowering scientists to decipher the complexities of living ...